These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32198144)

  • 21. Sea anemone model has a single Toll-like receptor that can function in pathogen detection, NF-κB signal transduction, and development.
    Brennan JJ; Messerschmidt JL; Williams LM; Matthews BJ; Reynoso M; Gilmore TD
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10122-E10131. PubMed ID: 29109290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Toll/IL-1 Receptor Homologous Region Adaptors Act as Negative Regulators in Amphioxus TLR Signaling.
    Peng J; Tao X; Li R; Hu J; Ruan J; Wang R; Yang M; Yang R; Dong X; Chen S; Xu A; Yuan S
    J Immunol; 2015 Oct; 195(7):3110-8. PubMed ID: 26324776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner.
    Zenke K; Muroi M; Tanamoto KI
    Cell Signal; 2018 Mar; 43():32-39. PubMed ID: 29242168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
    Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
    J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C; Flores MV; Chien A; Davidson A; Crosier K; Crosier P
    J Leukoc Biol; 2009 May; 85(5):751-65. PubMed ID: 19218482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of proteins that interact with the signal transduction molecule Dof and identification of a functional domain conserved between Dof and vertebrate BCAP.
    Battersby A; Csiszár A; Leptin M; Wilson R
    J Mol Biol; 2003 Jun; 329(3):479-93. PubMed ID: 12767830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
    Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
    Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR signaling pathways.
    Takeda K; Akira S
    Semin Immunol; 2004 Feb; 16(1):3-9. PubMed ID: 14751757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying the inhibition of TIR proteins involved in TLR signalling as an anti-inflammatory strategy.
    Saqib U; Baig MS
    SAR QSAR Environ Res; 2018 Apr; 29(4):295-318. PubMed ID: 29448819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmonella Coiled-Coil- and TIR-Containing TcpS Evades the Innate Immune System and Subdues Inflammation.
    Xiong D; Song L; Geng S; Jiao Y; Zhou X; Song H; Kang X; Zhou Y; Xu X; Sun J; Pan Z; Jiao X
    Cell Rep; 2019 Jul; 28(3):804-818.e7. PubMed ID: 31315056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
    Martin MU; Wesche H
    Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
    Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
    J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design of peptide derivatives for inhibition of MyD88-mediated toll-like receptor signaling in human peripheral blood mononuclear cells and epithelial cells exposed to Francisella tularensis.
    Ryan DA; Degardin M; Alam S; Kissner TL; Hale M; Cameron MD; Rebek M; Ajami D; Saikh KU; Rebek J
    Chem Biol Drug Des; 2017 Dec; 90(6):1190-1205. PubMed ID: 28599094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative regulation of Toll-like-receptor signaling by IRF-4.
    Negishi H; Ohba Y; Yanai H; Takaoka A; Honma K; Yui K; Matsuyama T; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15989-94. PubMed ID: 16236719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TIR domain-containing adaptors define the specificity of TLR signaling.
    Yamamoto M; Takeda K; Akira S
    Mol Immunol; 2004 Feb; 40(12):861-8. PubMed ID: 14698224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
    Lee SM; Kim EJ; Suk K; Lee WH
    J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
    Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
    Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.